Date:9/15/2009

cient to continue operations and complete the critical clinical trials; our ability to continue as a going concern; our ability to successfully develop products based on our technologies; our ability to obtain and maintain adequate levels of third-party reimbursement for our products; the impact of competitive products and pricing; our ability to receive regulatory approval for our products; the ability of third-party contract research organizations to perform preclinical testing and clinical trials for our technologies; the ability of third-party manufacturers to manufacture our products; our ability to retain the services of our key personnel; our ability to market and sell our products successfully; our ability to protect our intellectual property; product liability; changes in federal income tax laws and regulations; general market conditions in the medical device and pharmaceutical industries; and other matters that are described in Vicor's Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and subsequent filings with the Securities and Exchange Commission. Forward-looking statements in this press release speak only as of the date of the press release, and we assume no obligation to update forward-looking statements or the reasons why actual results could differ.

###

Read the full story at http://www.prweb.com/releases/medicaldiagnostics/suddencardiacdeath/prweb2885644.htm.

'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Nurse Turned Filmmaker Makes Lifesaving Film
2. Calling All Aspiring Filmmakers! The In The Know Short Film Competition Announces Call for Entries Women and Couples Encouraged to Enter TODAY, Share Their Fertility Stories and Inspire Others
3. Oscar-Nominated Filmmaker Alejandro Gonzalez Inarritu Directs New Meth Project Advertising Campaign
4. Recent Developments in Transplantation Headline AST Meeting
5. Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN(R) Over Crinone(R) for Progesterone Supplementation
6. Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
7. Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
8. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
9. Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
10. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
11. The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin